| The comprehensive antibiotic resistance database AG McArthur, N Waglechner, F Nizam, A Yan, MA Azad, AJ Baylay, ... Antimicrobial agents and chemotherapy 57 (7), 3348-3357, 2013 | 1764 | 2013 |
| The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism P Spanogiannopoulos, EN Bess, RN Carmody, PJ Turnbaugh Nature Reviews Microbiology 14 (5), 273-287, 2016 | 608 | 2016 |
| The tetracycline resistome M Thaker, P Spanogiannopoulos, GD Wright Cellular and Molecular Life Sciences 67, 419-431, 2010 | 397 | 2010 |
| Identifying producers of antibacterial compounds by screening for antibiotic resistance MN Thaker, W Wang, P Spanogiannopoulos, N Waglechner, AM King, ... Nature biotechnology 31 (10), 922-927, 2013 | 228 | 2013 |
| Cooking shapes the structure and function of the gut microbiome RN Carmody, JE Bisanz, BP Bowen, CF Maurice, S Lyalina, KB Louie, ... Nature microbiology 4 (12), 2052-2063, 2019 | 130 | 2019 |
| Caloric restriction disrupts the microbiota and colonization resistance RJ von Schwartzenberg, JE Bisanz, S Lyalina, P Spanogiannopoulos, ... Nature 595 (7866), 272-277, 2021 | 128 | 2021 |
| Phage-delivered CRISPR-Cas9 for strain-specific depletion and genomic deletions in the gut microbiome KN Lam, P Spanogiannopoulos, P Soto-Perez, M Alexander, MJ Nalley, ... Cell reports 37 (5), 2021 | 88 | 2021 |
| A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria P Spanogiannopoulos, N Waglechner, K Koteva, GD Wright Proceedings of the National Academy of Sciences 111 (19), 7102-7107, 2014 | 74 | 2014 |
| Genetic basis for the cooperative bioactivation of plant lignans by Eggerthella lenta and other human gut bacteria EN Bess, JE Bisanz, F Yarza, A Bustion, BE Rich, X Li, S Kitamura, ... Nature microbiology 5 (1), 56-66, 2020 | 64 | 2020 |
| Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetes P Spanogiannopoulos, M Thaker, K Koteva, N Waglechner, GD Wright Antimicrobial agents and chemotherapy 56 (10), 5061-5069, 2012 | 60 | 2012 |
| Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance PJ Stogios, P Spanogiannopoulos, E Evdokimova, O Egorova, T Shakya, ... Biochemical Journal 454 (2), 191-200, 2013 | 56 | 2013 |
| Rifampin phosphotransferase is an unusual antibiotic resistance kinase PJ Stogios, G Cox, P Spanogiannopoulos, MC Pillon, N Waglechner, ... Nature communications 7 (1), 11343, 2016 | 46 | 2016 |
| How to determine the role of the microbiome in drug disposition JE Bisanz, P Spanogiannopoulos, LM Pieper, AE Bustion, PJ Turnbaugh Drug Metabolism and Disposition 46 (11), 1588-1595, 2018 | 43 | 2018 |
| Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additives L Zou, P Spanogiannopoulos, LM Pieper, HC Chien, W Cai, N Khuri, ... Proceedings of the National Academy of Sciences 117 (27), 16009-16018, 2020 | 40 | 2020 |
| Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism P Spanogiannopoulos, TS Kyaw, BGH Guthrie, PH Bradley, JV Lee, ... Nature microbiology 7 (10), 1605-1620, 2022 | 26 | 2022 |
| Broad collateral damage of drugs against the gut microbiome P Spanogiannopoulos, PJ Turnbaugh Nature Reviews Gastroenterology & Hepatology 15 (8), 457-458, 2018 | 19 | 2018 |
| The enzymes of the rifamycin antibiotic resistome MD Surette, P Spanogiannopoulos, GD Wright Accounts of Chemical Research 54 (9), 2065-2075, 2021 | 16 | 2021 |
| The genetic basis for the cooperative bioactivation of plant lignans by a human gut bacterial consortium EN Bess, JE Bisanz, P Spanogiannopoulos, QY Ang, A Bustion, ... bioRxiv, 357640, 2018 | 10 | 2018 |
| Drug resistant gut bacteria mimic a host mechanism for anticancer drug clearance P Spanogiannopoulos, PH Bradley, J Melamed, YNA Malig, KN Lam, ... bioRxiv 10, 820084, 2019 | 3 | 2019 |
| Exploring Rifamycin Inactivation from the Soil Microbiome P Spanogiannopoulos | 1 | 2014 |
